Gulf Pharmaceutical Industries Overview

  • Year Founded
  • 1980

Year Founded

  • Status
  • Public

  • Employees
  • 1,968

Employees

  • Stock Symbol
  • JULPHAR

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $0.26
  • (As of Friday Closing)

Gulf Pharmaceutical Industries General Information

Description

Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.

Contact Information

Website
www.julphar.net
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • PO Box 997 Airport Road
  • Digdaga
  • Ras Al Khaimah United Arab Emirates
+971 07
Primary Industry
Pharmaceuticals
Stock Exchange
ADS
Corporate Office
  • PO Box 997 Airport Road
  • Digdaga
  • Ras Al Khaimah United Arab Emirates
+971 07

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gulf Pharmaceutical Industries Stock Performance

As of 20-Nov-2026, Gulf Pharmaceutical Industries’s stock price is $0.26. Its current market cap is $296M with 1.16B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.26 $0.26 $0.25 - $0.40 $296M 1.16B 1.08M $0.02

Gulf Pharmaceutical Industries Financials Summary

As of 30-Jun-2026, Gulf Pharmaceutical Industries has a trailing 12-month revenue of $300M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 333,425 375,967 652,204 495,609
Revenue 300,209 292,768 270,083 347,746
EBITDA 35,444 34,326 50,630 35,333
Net Income 19,165 46,876 12,140 (26,976)
Total Assets 504,505 484,497 659,989 667,946
Total Debt 74,316 74,860 264,290 302,303
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Gulf Pharmaceutical Industries Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gulf Pharmaceutical Industries‘s full profile, request access.

Request a free trial

Gulf Pharmaceutical Industries Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other t
Pharmaceuticals
Ras Al Khaimah, United Arab Emirates
1,968 As of 2025

Hyderabad, India
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gulf Pharmaceutical Industries Competitors (27)

One of Gulf Pharmaceutical Industries’s 27 competitors is Dr. Reddy's, a Corporation company based in Hyderabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dr. Reddy's Corporation Hyderabad, India
Sun Pharmaceutical Industries Corporation Mumbai, India
Evonile Pharma Private Equity-Backed Mumbai, India
Cipla Corporation Mumbai, India
Torrent Pharmaceuticals Corporation Ahmedabad, India
You’re viewing 5 of 27 competitors. Get the full list »

Gulf Pharmaceutical Industries Patents

Gulf Pharmaceutical Industries Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20050214365-A1 Taste, texture; no water required; formulated using pharmaburst (tm) proprietary disintegrant with talc, sodium stearyl fumarate, magnesium stearate and silicon dioxide as lubricants, potassium acesulfate sweetner, anise and mint flavors Inactive 24-Mar-2004
US-6365198-B1 Oral composition for amelioration or treatment of gastrointestinal ulcers and hemorrhoids comprising effective amounts of extracts of huanglian, huangqin, huangbo, pheretima, and opuntia Inactive 28-Jan-2001

Gulf Pharmaceutical Industries Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gulf Pharmaceutical Industries Investments & Acquisitions (4)

Gulf Pharmaceutical Industries’s most recent deal was a Merger/Acquisition with Planet Pharmacies. The deal was made on 13-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Planet Pharmacies 13-Jan-2022 Merger/Acquisition Distributors (Healthcare)
RAK Pharmaceuticals 10-Feb-2015 Merger/Acquisition Pharmaceuticals
Julphar Ethiopia 01-Feb-2013 Joint Venture Pharmaceuticals
Planet Pharmacies 01-Jan-2007 Joint Venture Distributors (Healthcare)
To view Gulf Pharmaceutical Industries’s complete investments and acquisitions history, request access »

Gulf Pharmaceutical Industries ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Gulf Pharmaceutical Industries’s complete esg history, request access »

Gulf Pharmaceutical Industries Exits (1)

Gulf Pharmaceutical Industries’s most recent exit was on 01-Feb-2013 from Julphar Ethiopia. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Julphar Ethiopia 01-Feb-2013 Completed
  • 2 buyers
To view Gulf Pharmaceutical Industries’s complete exits history, request access »

Gulf Pharmaceutical Industries Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Planet Pharmacies Dubai, United Arab Emirates 2007

Gulf Pharmaceutical Industries FAQs

  • When was Gulf Pharmaceutical Industries founded?

    Gulf Pharmaceutical Industries was founded in 1980.

  • Where is Gulf Pharmaceutical Industries headquartered?

    Gulf Pharmaceutical Industries is headquartered in Ras Al Khaimah, United Arab Emirates.

  • What is the size of Gulf Pharmaceutical Industries?

    Gulf Pharmaceutical Industries has 1,968 total employees.

  • What industry is Gulf Pharmaceutical Industries in?

    Gulf Pharmaceutical Industries’s primary industry is Pharmaceuticals.

  • Is Gulf Pharmaceutical Industries a private or public company?

    Gulf Pharmaceutical Industries is a Public company.

  • What is Gulf Pharmaceutical Industries’s stock symbol?

    The ticker symbol for Gulf Pharmaceutical Industries is JULPHAR.

  • What is the current stock price of Gulf Pharmaceutical Industries?

    As of 20-Nov-2026 the stock price of Gulf Pharmaceutical Industries is $0.26.

  • What is the current market cap of Gulf Pharmaceutical Industries?

    The current market capitalization of Gulf Pharmaceutical Industries is $296M.

  • What is Gulf Pharmaceutical Industries’s current revenue?

    The trailing twelve month revenue for Gulf Pharmaceutical Industries is $300M.

  • Who are Gulf Pharmaceutical Industries’s competitors?

    Dr. Reddy's, Sun Pharmaceutical Industries, Evonile Pharma, Cipla, and Torrent Pharmaceuticals are some of the 27 competitors of Gulf Pharmaceutical Industries.

  • What is Gulf Pharmaceutical Industries’s annual earnings per share (EPS)?

    Gulf Pharmaceutical Industries’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process